Cited by 1,033Alzheimer's disease research and treatmentsAutophagy in Disease and TherapyDementia and Cognitive Impairment Research

The DOI matches its Crossref record; 51 of the 52 references it cites were found in a registry or an index.

Inhibition of mTOR by Rapamycin Abolishes Cognitive Deficits and Reduces Amyloid-β Levels in a Mouse Model of Alzheimer's Disease

Open access

Spilman, Patricia, Podlutskaya, Natalia, Hart, Matthew J., Debnath, Jayanta, Gorostiza, Olivia, Bredesen, Dale, Richardson, Arlan, Strong, Randy, Galvan, Veronica·2010·PLoS ONE

DOI 10.1371/journal.pone.0009979PMC PMC2848616

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: Reduced TOR signaling has been shown to significantly increase lifespan in a variety of organisms [1], [2], [3], [4]. It was recently demonstrated that long-term treatment with rapamycin, an inhibitor of the mTOR pathway[5], or ablation of the mTOR target p70S6K[6] extends lifespan in mice, possibly by delaying aging. Whether inhibition of the mTOR pathway would delay or prevent age-associated disease such as AD remained to be determined. METHODOLOGY/PRINCIPAL FINDINGS: We used rapamycin administration and behavioral tools in a mouse model of AD as well as standard biochemical and immunohistochemical measures in brain tissue to provide answers for this question. Here we show that long-term inhibition of mTOR by rapamycin prevented AD-like cognitive deficits and lowered levels of Abeta(42), a major toxic species in AD[7], in the PDAPP transgenic mouse model. These data indicate that inhibition of the mTOR pathway can reduce Abeta(42) levels in vivo and block or delay AD in mice. As expected from the inhibition of mTOR, autophagy was increased in neurons of rapamycin-treated transgenic, but not in non-transgenic, PDAPP mice, suggesting that the reduction in Abeta and the improvement in cognitive function are due in part to increased autophagy, possibly as a response to high levels of Abeta. CONCLUSIONS/SIGNIFICANCE: Our data suggest that inhibition of mTOR by rapamycin, an intervention that extends lifespan in mice, can slow or block AD progression in a transgenic mouse model of the disease. Rapamycin, already used in clinical settings, may be a potentially effective therapeutic agent for the treatment of AD.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0009979

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Developments of a water-maze procedure for studying spatial learning in the rat
Morris, R. (1984) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(84)90007-4 · Cited by 7,180
LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing.
Kabeya, Y., Mizushima, N., Ueno, T., Yamamoto, A., Kirisako, T., Noda, T., Kominami, E., Ohsumi, Y., & Yoshimori, T. (2000) · The EMBO Journal · doi:10.1093/emboj/19.21.5720 · Cited by 6,605
Alzheimer's Disease Is a Synaptic Failure
Selkoe, D. J. (2002) · Science · doi:10.1126/science.1074069 · Cited by 4,420
Rapamycin fed late in life extends lifespan in genetically heterogeneous mice
Harrison, D. E., Strong, R., Sharp, Z. D., Nelson, J. F., Astle, C. M., Flurkey, K., Nadon, N. L., Wilkinson, J. E., Frenkel, K., Carter, C. S., et al. (2009) · Nature · doi:10.1038/nature08221 · Cited by 3,766
Self-citation
p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death
Bjørkøy, G., Lamark, T., Brech, A., Outzen, H., Perander, M., Øvervatn, A., Stenmark, H., & Johansen, T. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200507002 · Cited by 3,276
Prolonged Rapamycin Treatment Inhibits mTORC2 Assembly and Akt/PKB
Sarbassov, D. D., Ali, S. M., Sengupta, S., Sheen, J.-H., Hsu, P. P., Bagley, A. F., Markhard, A. L., & Sabatini, D. M. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.03.029 · Cited by 2,365
Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease
Ravikumar, B., Vacher, C., Berger, Z., Davies, J. E., Luo, S., Oroz, L. G., Scaravilli, F., Easton, D. F., Duden, R., O'Kane, C. J., et al. (2004) · Nature Genetics · doi:10.1038/ng1362 · Cited by 2,347
A mammalian protein targeted by G1-arresting rapamycin–receptor complex
Brown, E. J., Albers, M. W., Bum Shin, T., ichikawa, K., Keith, C. T., Lane, W. S., & Schreiber, S. L. (1994) · Nature · doi:10.1038/369756a0 · Cited by 2,053
FoxO3 Controls Autophagy in Skeletal Muscle In Vivo
Mammucari, C., Milan, G., Romanello, V., Masiero, E., Rudolf, R., Del Piccolo, P., Burden, S. J., Di Lisi, R., Sandri, C., Zhao, J., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.11.001 · Cited by 1,953
Reducing Endogenous Tau Ameliorates Amyloid ß-Induced Deficits in an Alzheimer's Disease Mouse Model
Roberson, E. D., Scearce-Levie, K., Palop, J. J., Yan, F., Cheng, I. H., Wu, T., Gerstein, H., Yu, G.-Q., & Mucke, L. (2007) · Science · doi:10.1126/science.1141736 · Cited by 1,892

Flagged first, then by citations

Show all 52 references

1 of the 52 references couldn’t be matched to a known paper.

Sorted by citations

Items 201–300 of 998

RETRACTED ARTICLE: p62 improves AD-like pathology by increasing autophagy
Caccamo, A., Ferreira, E., Branca, C., & Oddo, S. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.139 · Cited by 108
Retracted
Inhibiting ACAT1/SOAT1 in microglia stimulates autophagy-mediated lysosomal proteolysis and increases Aβ1-42 clearance
Shibuya, Y., Chang, C. C. Y., Huang, L.-H., Bryleva, E. Y., & Chang, T.-Y. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.2567-14.2014 · Cited by 108
“In mouse models of AD, studies have shown that blocking mTOR by rapamycin administration increases autophagy in the brain, reduces A 1– 42 levels, and rescues cognitive deficits (Caccamo et al., 2010; Spilman et al., 2010).”
Background
Modeling human neurodegenerative diseases in transgenic systems
Sosa, M. A. G., Gasperi, R. D., & Elder, G. A. (2011) · Human Genetics · doi:10.1007/s00439-011-1119-1 · Cited by 114
Rapamycin Delays Disease Onset and Prevents PrP Plaque Deposition in a Mouse Model of Gerstmann–Sträussler–Scheinker Disease
Cortés, C. J., Qin, K., Cook, J., Solanki, A., & Mastrianni, J. A. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.6189-11.2012 · Cited by 113
Inflammation and Insulin Resistance as Risk Factors and Potential Therapeutic Targets for Alzheimer’s Disease
Vinuesa, Á., Pomilio, C. J., Gregosa, A., Bentivegna, M., Presa, J., Bellotto, M., Saravia, F., & Beauquis, J. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.653651 · Cited by 117
Facilitated ethanol metabolism promotes cardiomyocyte contractile dysfunction through autophagy in murine hearts
Guo, R., Hu, N., Kandadi, M. R., & Ren, J. T. (2012) · Autophagy · doi:10.4161/auto.18997 · Cited by 108
Metformin attenuates plaque-associated tau pathology and reduces amyloid-β burden in APP/PS1 mice
Chen, Y., Zhao, S., Fan, Z., Li, Z., Zhu, Y., Shen, T., Li, K., Yan, Y., Tian, J., Liu, Z., et al. (2021) · Alzheimer's Research & Therapy · doi:10.1186/s13195-020-00761-9 · Cited by 111
Protein Homeostasis, Aging and Alzheimer’s Disease
Morawe, T., Hiebel, C., Kern, A., & Behl, C. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8246-0 · Cited by 105
mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders
Ryskalin, L., Limanaqi, F., Frati, A., Busceti, C. L., & Fornai, F. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19082226 · Cited by 110
Autophagy in ageing and ageing-associated diseases
He, L., Lu, J., & Yue, Z. (2013) · Acta Pharmacologica Sinica · doi:10.1038/aps.2012.188 · Cited by 107
Metformin Facilitates Amyloid-β Generation by β- and γ -Secretases via Autophagy Activation
Son, S. M., Shin, H., Byun, J., Kook, S. Y., Moon, M., Chang, Y. J., & Mook‐Jung, I. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-151200 · Cited by 106
Alzheimer’s Disease and Cancer: When Two Monsters Cannot Be Together
Majd, S., Power, J., & Majd, Z. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00155 · Cited by 102
Biosynthesis of the immunosuppressants FK506, FK520, and rapamycin involves a previously undescribed family of enzymes acting on chorismate
Andexer, J. N., Kendrew, S. G., Nur‐e‐Alam, M., Lazos, O., Foster, T. A., Zimmermann, A.-S., Warneck, T. D., Suthar, D., Coates, N. J., Koehn, F. E., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1015773108 · Cited by 104
Therapeutic activation of autophagy by combined treatment with rapamycin and trehalose in a mouse MPTP-induced model of Parkinson's disease
Pupyshev, A. B., Tikhonova, M. A., Akopyan, A. A., Tenditnik, M. V., Dubrovina, N. I., & Короленко, Т. А. (2018) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2018.12.005 · Cited by 107
The Multiple Roles of Autophagy in Neural Function and Diseases
Li, Y., Qin, Z., & Sheng, R. (2023) · Neuroscience Bulletin · doi:10.1007/s12264-023-01120-y · Cited by 109
Glycolytic inhibition as a strategy for developing calorie restriction mimetics
Ingram, D. K., & Roth, G. S. (2010) · Experimental Gerontology · doi:10.1016/j.exger.2010.12.001 · Cited by 104
ACAT1/SOAT1 as a Therapeutic Target for Alzheimer's Disease
Shibuya, Y., Chang, C. C., & Chang, T.-Y. (2015) · Future Medicinal Chemistry · doi:10.4155/fmc.15.161 · Cited by 113
Rapamycin induces glucose intolerance in mice by reducing islet mass, insulin content, and insulin sensitivity
Yang, S., Lee, H. Y., Young, D. M., Tien, A., Rowson-Baldwin, A., Shu, Y., Jan, Y. N., & Jan, L. Y. (2011) · Journal of Molecular Medicine · doi:10.1007/s00109-011-0834-3 · Cited by 109
Long-term treadmill exercise attenuates tau pathology in P301S tau transgenic mice
Ohia-Nwoko, O., Montazari, S., Lau, Y., & Eriksen, J. L. (2014) · Molecular Neurodegeneration · doi:10.1186/1750-1326-9-54 · Cited by 108
Glucocorticoids Modulate the mTOR Pathway in the Hippocampus: Differential Effects Depending on Stress History
Polman, J. A. E., Hunter, R. G., Speksnijder, N., van den Oever, J. M. E., Korobko, O. B., McEwen, B. S., de Kloet, E. R., & Datson, N. A. (2012) · Endocrinology · doi:10.1210/en.2012-1255 · Cited by 104
Interplay Between the Autophagy-Lysosomal Pathway and the Ubiquitin-Proteasome System: A Target for Therapeutic Development in Alzheimer’s Disease
Bustamante, H. A., González, A., Cerda‐Troncoso, C., Shaughnessy, R., Carola Otth, L., Soza, A., & Burgos, P. V. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00126 · Cited by 102
Intranasal rapamycin ameliorates Alzheimer-like cognitive decline in a mouse model of Down syndrome
Tramutola, A., Lanzillotta, C., Barone, E., Arena, A., Zuliani, I., Mosca, L., Blarzino, C., Butterfield, D. A., Marzia Perluigi, A., & Domenico, F. D. (2018) · Translational Neurodegeneration · doi:10.1186/s40035-018-0133-9 · Cited by 102
Down Syndrome Is a Metabolic Disease: Altered Insulin Signaling Mediates Peripheral and Brain Dysfunctions
Dierssen, M., Fructuoso, M., de Lagrán, M. M., Marzia Perluigi, A., & Barone, E. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00670 · Cited by 106
Neuronal and glial alterations, increased anxiety, and cognitive impairment before hippocampal amyloid deposition in PDAPP mice, model of Alzheimer's disease
Beauquis, J., Vinuesa, Á., Pomilio, C. J., Pavía, P., Galván, V., & Saravia, F. (2013) · Hippocampus · doi:10.1002/hipo.22219 · Cited by 101
Crosstalk Between Macroautophagy and Chaperone-Mediated Autophagy: Implications for the Treatment of Neurological Diseases
Wu, H., Chen, S., Al-Baadani, A., Xu, J., Wu, Q., Pan, K., Zhang, J., & Hong, Y. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8933-0 · Cited by 103
Tau and mTOR: The Hotspots for Multifarious Diseases in Alzheimer's Development
Mueed, Z., Tandon, P., Maurya, S. K., Deval, R., Kamal, M. A., & Poddar, N. K. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.01017 · Cited by 111
Role of age-related alterations of the cerebral venous circulation in the pathogenesis of vascular cognitive impairment
Fülöp, G., Tarantini, S., Yabluchanskiy, A., Molnár, A., Prodan, C. I., Kiss, T., Csípő, T., Lipécz, Á., Balasubramanian, P., Farkas, E., et al. (2019) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00776.2018 · Cited by 101
Insights into CNS ageing from animal models of senescence
Yeoman, M. S., Scutt, G., & Faragher, R. (2012) · Nature reviews. Neuroscience · doi:10.1038/nrn3230 · Cited by 98
Decreased mTOR signalling reduces mitochondrial ROS in brain via accumulation of the telomerase protein TERT within mitochondria
Miwa, S., Czapiewski, R., Wan, T., Bell, A., Hill, K. N., von Zglinicki, T., & Saretzki, G. C. (2016) · Aging · doi:10.18632/aging.101089 · Cited by 100
The role of mTOR signaling pathway in spinal cord injury
Kanno, H., Ozawa, H., Sekiguchi, A., Yamaya, S., Tateda, S., Yahata, K., & Itoi, E. (2012) · Cell Cycle · doi:10.4161/cc.21262 · Cited by 97
Corynoxine, a Natural Autophagy Enhancer, Promotes the Clearance of Alpha-Synuclein via Akt/mTOR Pathway
Chen, L., Song, J., Lu, J., Yuan, Z., Liu, L., Durairajan, S. S. K., & Li, M. (2014) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-014-9528-2 · Cited by 97
Cognitive reserve, cortical plasticity and resistance to Alzheimer's disease
Esiri, M. M., & Chance, S. A. (2012) · Alzheimer's Research & Therapy · doi:10.1186/alzrt105 · Cited by 95
mTOR kinase, a key player in the regulation of glial functions: Relevance for the therapy of multiple sclerosis
Dello Russo, C., Lisi, L., Feinstein, D. L., & Navarra, P. (2013) · Glia · doi:10.1002/glia.22433 · Cited by 96
Intestinal barrier dysfunction: an evolutionarily conserved hallmark of aging
Salazar, A. M., Aparício, R., Clark, R. I., Rera, M., & Walker, D. W. (2023) · Disease Models & Mechanisms · doi:10.1242/dmm.049969 · Cited by 98
mTOR signaling and Alzheimer's disease: What we know and where we are?
Davoody, S., Asgari Taei, A., Khodabakhsh, P., & Dargahi, L. (2024) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14463 · Cited by 96
Rapamycin modulates tissue aging and lifespan independently of the gut microbiota in Drosophila
Schinaman, J. M., Rana, A., Ja, W. W., Clark, R. I., & Walker, D. W. (2019) · Scientific Reports · doi:10.1038/s41598-019-44106-5 · Cited by 99
Longitudinal follow-up of autophagy and inflammation in brain of APPswePS1dE9 transgenic mice
François, A., Bilan, A. R., Quellard, N., Fernandez, B., Janet, T., Chassaing, D., Paccalin, M., Terro, F., & Page, G. (2014) · Journal of Neuroinflammation · doi:10.1186/s12974-014-0139-x · Cited by 98
Therapeutic implication of autophagy in neurodegenerative diseases
Rahman, M. A., & Rhim, H. (2017) · BMB Reports · doi:10.5483/bmbrep.2017.50.7.069 · Cited by 100
Deconvoluting mTOR biology
Weber, J. D., & Gutmann, D. H. (2012) · Cell Cycle · doi:10.4161/cc.11.2.19022 · Cited by 97
Resveratrol Attenuates Aβ25–35 Caused Neurotoxicity by Inducing Autophagy Through the TyrRS-PARP1-SIRT1 Signaling Pathway
Deng, H., & Mi, M. (2016) · Neurochemical Research · doi:10.1007/s11064-016-1950-9 · Cited by 96
Concerted Perturbation Observed in a Hub Network in Alzheimer’s Disease
Liang, D., Han, G., Feng, X., Sun, J., Duan, Y., & Lei, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040498 · Cited by 93
Precision medicine in Parkinson’s disease: emerging treatments for genetic Parkinson’s disease
Schneider, S. A., & Alcalay, R. N. (2020) · Journal of Neurology · doi:10.1007/s00415-020-09705-7 · Cited by 99
The mTOR Signaling Pathway in the Brain: Focus on Epilepsy and Epileptogenesis
Russo, E., Citraro, R., Constanti, A., & Sarro, G. D. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8314-5 · Cited by 91
Rapamycin, Autophagy, and Alzheimer's Disease.
Cai, Z., & Yan, L. (2013) · PubMed · Cited by 97
Cholesterol homeostasis: a key to prevent or slow down neurodegeneration
Anchisi, L., Dessì, S., Pani, A., & Mandas, A. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2012.00486 · Cited by 91
Erythropoietin: New Directions for the Nervous System
Maiese, K., Chong, Z. Z., Shang, Y. C., & Wang, S. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms130911102 · Cited by 92
Neurodegenerative Pathways in Alzheimer’s Disease: A Review
Ramachandran, A. K., Das, S., Joseph, A., Shenoy, G. G., Alex, A. T., & Mudgal, J. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200807130637 · Cited by 94
Enhancing autophagy in Alzheimer's disease through drug repositioning
Eshraghi, M., Ahmadi, M., Afshar, S., Lorzadeh, S., Adlimoghaddam, A., Rezvani Jalal, N., West, R., Dastghaib, S., Igder, S., Torshizi, S. R. N., et al. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108171 · Cited by 89
mTOR in Down syndrome: Role in Aß and tau neuropathology and transition to Alzheimer disease-like dementia
Di Domenico, F., Tramutola, A., Foppoli, C., Head, E., Perluigi, M., & Butterfield, D. A. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.08.009 · Cited by 89
Glycolytic-to-oxidative fiber-type switch and mTOR signaling activation are early-onset features of SBMA muscle modified by high-fat diet
Rocchi, A., Milioto, C., Parodi, S., Armirotti, A., Borgia, D., Pellegrini, M., Urciuolo, A., Molon, S., Morbidoni, V., Marabita, M., et al. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1550-4 · Cited by 90
Autophagy stimulation as a promising approach in treatment of neurodegenerative diseases
Pierzynowska, K., Gaffke, L., Cyske, Z., Puchalski, M., Rintz, E., Bartkowski, M., Osiadły, M., Pierzynowski, M., Mantej, J., Piotrowska, E., et al. (2018) · Metabolic Brain Disease · doi:10.1007/s11011-018-0214-6 · Cited by 93
Promoting Autophagic Clearance: Viable Therapeutic Targets in Alzheimer's Disease
Friedman, L. G., Qureshi, Y. H., & Yu, W. H. (2014) · Neurotherapeutics · doi:10.1007/s13311-014-0320-z · Cited by 89
Aging and gastrointestinal neuromuscular function: insights from within and outside the gut
Bitar, K. N., Meerveld, B. G., Saad, R., & Wiley, J. W. (2011) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2011.01678.x · Cited by 91
Divergent tissue and sex effects of rapamycin on the proteasome-chaperone network of old mice
Rodriguez, K. A., Dodds, S. G., Strong, R., Galván, V., Sharp, Z. D., & Buffenstein, R. (2014) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2014.00083 · Cited by 86
Self-citation
TREM2‐dependent effects on microglia in Alzheimer's disease
Zhou, Y., Ulland, T. K., & Colonna, M. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00202 · Cited by 82
mTOR-dependent translation amplifies microglia priming in aging mice
Keane, L., Antignano, I., Riechers, S., Zollinger, R., Dumas, A. A., Offermann, N., Bernis, M. E., Russ, J., Graelmann, F. J., McCormick, P. N., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci132727 · Cited by 93
Rapamycin Is Neuroprotective in a Rat Chronic Hypertensive Glaucoma Model
Su, W., Li, Z., Jia, Y., & Zhuo, Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099719 · Cited by 86
Rapamycin activates autophagy in Hutchinson-Gilford progeria syndrome
Graziotto, J. J., Cao, K., Collins, F. S., & Krainc, D. (2012) · Autophagy · doi:10.4161/auto.8.1.18331 · Cited by 91
Targeting the Prodromal Stage of Alzheimer's Disease: Bioenergetic and Mitochondrial Opportunities
Caldwell, C. C., Yao, J., & Brinton, R. D. (2014) · Neurotherapeutics · doi:10.1007/s13311-014-0324-8 · Cited by 86
mTORC Inhibitors as Broad-Spectrum Therapeutics for Age-Related Diseases
Walters, H. E., & Cox, L. S. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19082325 · Cited by 85
Tauopathies: Deciphering Disease Mechanisms to Develop Effective Therapies
Silva, M. C., & Haggarty, S. J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21238948 · Cited by 89
Autophagic activity in neuronal cell death
Button, R. W., Luo, S., & Rubinsztein, D. C. (2015) · Neuroscience Bulletin · doi:10.1007/s12264-015-1528-y · Cited by 88
Amyloid-β Oligomers Induce Differential Gene Expression in Adult Human Brain Slices
Sebollela, A. S., Freitas-Corrêa, L., de Oliveira, F. F., Paula-Lima, A. C., Saraiva, L. M., Martins, S. M., Mota, L. D. C., Torres, C., Alves‐Leon, S. V., de Souza, J. M., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.298471 · Cited by 90
Mitochondrial quality control: The role of mitophagy in aging
Shi, R., Guberman, M., & Kirshenbaum, L. A. (2017) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2017.11.008 · Cited by 87
Defective proteostasis in Alzheimer’s disease
Cozachenco, D., Ribeiro, F. C., & Ferreira, S. T. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101862 · Cited by 87
Over‐expression of heat shock factor 1 phenocopies the effect of chronic inhibition of TOR by rapamycin and is sufficient to ameliorate Alzheimer's‐like deficits in mice modeling the disease
Pierce, A. P., Podlutskaya, N., Halloran, J. J., Hussong, S. A., Lin, P., Burbank, R. R., Hart, M. J., & Galván, V. (2012) · Journal of Neurochemistry · doi:10.1111/jnc.12080 · Cited by 87
Self-citation
Preserving Lysosomal Function in the Aging Brain: Insights from Neurodegeneration
Peng, W., Minakaki, G., Nguyen, M., & Krainc, D. (2019) · Neurotherapeutics · doi:10.1007/s13311-019-00742-3 · Cited by 79
NRBF2 is involved in the autophagic degradation process of APP-CTFs in Alzheimer disease models
Yang, C., Cai, C.-Z., Song, J.-X., Tan, J.-Q., Durairajan, S. S. K., Iyaswamy, A., Wu, M.-Y., Chen, L.-L., Yue, Z., Li, M., et al. (2017) · Autophagy · doi:10.1080/15548627.2017.1379633 · Cited by 83
Imaging of cerebrovascular pathology in animal models of Alzheimer's disease
Klohs, J., Rudin, M., Shimshek, D. R., & Beckmann, N. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00032 · Cited by 82
Taking aim at Alzheimer's disease through the mammalian target of rapamycin
Maiese, K. (2014) · Annals of Medicine · doi:10.3109/07853890.2014.941921 · Cited by 88
Shedding new light on neurodegenerative diseases through the mammalian target of rapamycin
Chong, Z. Z., Shang, Y. C., Wang, S., & Maiese, K. (2012) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2012.08.001 · Cited by 119
Glial alterations from early to late stages in a model of A lzheimer's disease: Evidence of autophagy involvement in A β internalization
Pomilio, C. J., Pavía, P., Gorojod, R. M., Vinuesa, Á., Alaimo, A., Galván, V., Kotler, M. L., Beauquis, J., & Saravia, F. (2015) · Hippocampus · doi:10.1002/hipo.22503 · Cited by 82
Driving neural regeneration through the mammalian target of rapamycin
Maiese, K. (2014) · Neural Regeneration Research · doi:10.4103/1673-5374.139453 · Cited by 80
Endo-lysosomal pathway and ubiquitin-proteasome system dysfunction in Alzheimer's disease pathogenesis
Cao, J., Zhong, M. B., Toro, C. A., Zhang, L., & Cai, D. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.03.016 · Cited by 82
Targeting Cell Senescence and Senolytics: Novel Interventions for Age-Related Endocrine Dysfunction
Suda, M., Paul, K. H., Tripathi, U., Minamino, T., Tchkonia, T., & Kirkland, J. L. (2024) · Endocrine Reviews · doi:10.1210/endrev/bnae010 · Cited by 83
Autophagy in Aging and Alzheimer's Disease: Pathologic or Protective?
Barnett, A., & Brewer, G. J. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-101989 · Cited by 76
Molecular mechanisms for anti‐aging by natural dietary compounds
Pan, M., Lai, C., Tsai, M., Wu, J.-C., & Ho, C. (2011) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201100509 · Cited by 78
Insulin resistance as the molecular link between diabetes and Alzheimer's disease
Abdalla, M. M. I. (2024) · World Journal of Diabetes · doi:10.4239/wjd.v15.i7.1430 · Cited by 83
Convergent pathogenic pathways in Alzheimer's and Huntington's diseases: shared targets for drug development
Ehrnhoefer, D. E., Wong, B. K. Y., & Hayden, M. R. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3556 · Cited by 78
Evaluating the Effectiveness of GTM-1, Rapamycin, and Carbamazepine on Autophagy and Alzheimer Disease
Zhang, L., Wang, L., Wang, R., Gao, Y., Che, H., Pan, Y., & Fu, P. (2017) · Medical Science Monitor · doi:10.12659/msm.898679 · Cited by 78
Molecular Mechanisms of Lithium Action: Switching the Light on Multiple Targets for Dementia Using Animal Models
Kerr, F., Bjedov, I., & Sofola-Adesakin, O. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00297 · Cited by 80
Influence of Normal Aging on Brain Autophagy: A Complex Scenario
Loeffler, D. A. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00049 · Cited by 79
Targeting autophagy in Alzheimer’s disease: Animal models and mechanisms
Zhang, X.-W., 澳门大学中华医药研究院中药质量研究国家重点实验室, 澳. 凼. 9., State Key Laboratory of Quality Research in Chinese Medicine, I. O. C. M. S., Zhu, X.-X., Tang, D.-S., Lu, J.-H., 佛山大学广东省动物分子设计与精准育种重点实验室, 广., & Guangdong Provincial Key Laboratory of Animal Molecular Design and Precise Breeding, G. E. T. C. O. G. P. (2023) · Zoological Research · doi:10.24272/j.issn.2095-8137.2023.294 · Cited by 77
“Inhibition of mTOR-dependent pathways markedly increases autophagy and reduces both intracellular Aβ and extracellular amyloid deposition in the brain (Cai & Yan, 2013; Spilman et al., 2010).”
Background
Programmed Death of Microglia in Alzheimer's Disease: Autophagy, Ferroptosis, and Pyroptosis
Qiu, Z., Zhang, H., Xia, M., Gu, J., Guo, K., Wang, H., & Miao, C. (2023) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2023.3 · Cited by 77
Dysfunction of the mTOR pathway is a risk factor for Alzheimer's disease
Yates, S. C., Zafar, A., Hubbard, P., Nagy, S., Durant, S., Bicknell, R., Wilcock, G., Christie, S., Esiri, M. M., Smith, A. D., et al. (2013) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-1-3 · Cited by 76
Regulation of Cardiac Expression of the Diabetic Marker MicroRNA miR-29
Arnold, N., Koppula, P. R., Gul, R., Luck, C., & Pulakat, L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103284 · Cited by 76
Geniposide-mediated protection against amyloid deposition and behavioral impairment correlates with downregulation of mTOR signaling and enhanced autophagy in a mouse model of Alzheimer's disease
Zhang, Z., Wang, X., Zhang, D., Liu, Y., & Lin, L. (2019) · Aging · doi:10.18632/aging.101759 · Cited by 76
AMPK activation does not enhance autophagy in neurons in contrast to MTORC1 inhibition: different impact on β-amyloid clearance
Benito‐Cuesta, I., Ordóñez‐Gutiérrez, L., & Wandosell, F. G. (2020) · Autophagy · doi:10.1080/15548627.2020.1728095 · Cited by 80
Mammalian target of rapamycin hyperactivity mediates the detrimental effects of a high sucrose diet on Alzheimer's disease pathology
Orr, M. E., Salinas, A., Buffenstein, R., & Oddo, S. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.12.006 · Cited by 78
Neuroprotective effects of mesenchymal stem cells through autophagy modulation in a parkinsonian model
Park, H.-J., Shin, J. Y., Kim, H., Oh, S. H., & Lee, P. H. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.01.028 · Cited by 73
Health Effects of Long-Term Rapamycin Treatment: The Impact on Mouse Health of Enteric Rapamycin Treatment from Four Months of Age throughout Life
Fischer, K. E., Gelfond, J., Soto, V. Y., Han, C. J., Someya, S., Richardson, A., & Austad, S. N. (2015) · PLoS ONE · doi:10.1371/journal.pone.0126644 · Cited by 77
Self-citation
Neuroprotective Effects of Temsirolimus in Animal Models of Parkinson’s Disease
Siracusa, R., Paterniti, I., Cordaro, M., Crupi, R., Bruschetta, G., Campolo, M., Cuzzocrea, S., & Esposito, E. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0496-4 · Cited by 74
Autophagy in Astrocytes and its Implications in Neurodegeneration
Sung, K., & Jiménez-Sánchez, M. (2020) · Journal of Molecular Biology · doi:10.1016/j.jmb.2019.12.041 · Cited by 78
Neuroprotective Effect of Ligustilide through Induction of α-Secretase Processing of Both APP and Klotho in a Mouse Model of Alzheimer’s Disease
Kuang, X., Zhou, H., Thorne, A. H., Chen, X.-N., Li, L.-J., & Du, J. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00353 · Cited by 74
Neuronally derived extracellular vesicles: an emerging tool for understanding Alzheimer’s disease
Watson, L. S., Hamlett, E. D., Stone, T. D., & Sims‐Robinson, C. (2019) · Molecular Neurodegeneration · doi:10.1186/s13024-019-0317-5 · Cited by 75
The role of the TOR pathway in mediating the link between nutrition and longevity
Lushchak, O., Strilbytska, O., Piskovatska, V., Storey, K. B., Koliada, A., & Vaiserman, A. (2017) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2017.03.005 · Cited by 73
Light-Activated ROS Production Induces Synaptic Autophagy
Hoffmann, S., Orlando, M., Andrzejak, E., Bruns, C., Trimbuch, T., Rosenmund, C., Garner, C. C., & Ackermann, F. (2019) · Journal of Neuroscience · doi:10.1523/jneurosci.1317-18.2019 · Cited by 71
Crosstalk between the mTOR and Nrf2/ARE signaling pathways as a target in the improvement of long-term potentiation
Gureev, A. P., Popov, V. N., & Starkov, A. A. (2020) · Experimental Neurology · doi:10.1016/j.expneurol.2020.113285 · Cited by 75
Neuronal stress signaling and eIF2α phosphorylation as molecular links between Alzheimer's disease and diabetes
Lourenco, M. V., Ferreira, S. T., & Felice, F. G. D. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.03.003 · Cited by 74
Mammalian models of extended healthy lifespan
Selman, C., & Withers, D. J. (2010) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2010.0243 · Cited by 75

Authors: Spilman, P., Podlutskaya, N., Hart, M. J., Debnath, J., Gorostiza, O., Bredesen, D., Richardson, A., Strong, R., & Galvan, V.
Affiliations: Buck Institute for Research on Aging (US)
The University of Texas at San Antonio Health Science Center (US)
University of California, San Francisco (US)
ORCID: Spilman, Patricia
Hart, Matthew J.
Debnath, Jayanta
Bredesen, Dale
Richardson, Arlan
Strong, Randy
Venue: PLoS ONE
Publisher: Public Library of Science (PLoS)
Published: 2010-04-01
Volume: 5
Issue: 4
Pages: e9979
ISSN: 1932-6203 (ISSN-L)
DOI: 10.1371/journal.pone.0009979
PMC: PMC2848616
OpenAlex: W2037653131
Cited by: 1,033
References: 52
Citations by year: 2026: 46 · 2025: 50 · 2024: 41 · 2023: 63 · 2022: 61 · 2021: 75 · 2020: 91 · 2019: 82 · 2018: 72 · 2017: 57 · 2016: 68 · 2015: 75 · 2014: 72 · 2013: 62 · 2012: 58
FWCI: 39.00
Type: journal article
Language: en
Update notices: correction (2011-12-27)
correction (2011-11-18)
Open access: gold
doi.org
Licence: cc-by
creativecommons.org/licenses/by/4.0/ (unspecified)
Locations: PLoS ONE (publishedVersion, cc-by)
PubMed Central (publishedVersion, cc-by)
PubMed (publishedVersion)
DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
eScholarship (California Digital Library) (submittedVersion)
eScholarship (California Digital Library) (submittedVersion, cc-by)
Funders: U.S. Department of Veterans Affairs
Alzheimer's Association (NIRG-DDC-120433)
Buck Institute for Research on Aging
University of Texas Health Science Center at San Antonio
National Institute on Aging (P30AG13319, P30AG013319, U01AG022307)
National Cancer Institute (R01CA126792)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords: rapamycin, mTOR inhibition, Alzheimer's disease, amyloid-beta 42, cognitive impairment, autophagy, lifespan extension, neuroprotection, therapeutic target
MeSH terms: Aging, Alzheimer Disease, Animals, Autophagy, Cognition Disorders, Disease Models, Animal, Immunosuppressive Agents, Signal Transduction, Amyloid beta-Peptides, Sirolimus, Mice, TOR Serine-Threonine Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Inhibition of mTOR by Rapamycin Abolishes Cognitive Deficits and Reduces Amyloid-β Levels in a Mouse Model of Alzheimer's Disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks